Hyaluronidase is the most important emergency tool in HA filler medicine. Anyone who chooses hyaluronic acid treatment should know: a practice without hyaluronidase on hand is not safe. This article describes what hyaluronidase does, when it is used, and what conditions must be met — without symptom triage and without self-diagnosis instructions.
What hyaluronidase is
Hyaluronidase is an enzyme that can cleave hyaluronic acid. It exists endogenously, but in medicine it is used as an injectable formulation to dissolve hyaluronic acid that has been placed in the body. In aesthetic medicine: the only available tool to actively remove misplaced or complication-causing HA filler.
The enzyme acts quickly. Within hours to a few days, implanted hyaluronic acid can be measurably broken down. The exact speed depends on the cross-linking of the filler product, the hyaluronidase dose, the location, and the time since injection. A review by DeLorenzi (2017) in the Aesthetic Surgery Journal describes the pharmacodynamics in detail [1].
When hyaluronidase is used
Two fundamentally different scenarios.
Acute emergency indication: suspected vascular event
The most important indication. With suspicion of arterial filler embolism or venous congestion, hyaluronidase is the time-critical intervention. It dissolves the filler material and can restore vascular perfusion before irreversible damage sets in. The window is narrow — usually hours, not days.
A retrospective analysis by Beleznay et al. (2019) of severe filler complications worldwide shows that hyaluronidase availability and rapid use are the decisive factors in damage limitation [2]. A practice that cannot access this substance within minutes should not inject HA fillers.
Elective correction: unwanted result
The second use: controlled dissolution of filler material that should be removed for aesthetic reasons. Asymmetry, visible nodules, cumulative volume overload from previous treatments, dissatisfaction with the result. Here hyaluronidase is not an emergency tool but a planned therapy.
Important caveat: hyaluronidase dissolves hyaluronic acid — it does not distinguish between filler HA and endogenous HA. Higher doses can temporarily affect the body's own hyaluronic acid. Careful dosing is therefore central.
What a practice must have in place
Anyone injecting HA fillers carries responsibility that does not end with the syringe. Standard medical care includes:
Hyaluronidase available in the treatment room. Not in the order pipeline, not at the pharmacy down the street. In the room. With current expiry date, correct storage, immediate access.
Documented emergency algorithm. Written protocol, clear responsibilities, telephone reachability outside practice hours.
Treatment documentation. Which filler, which lot, which location, which volume. In a complication, the treating physician must be able to plan a precise countermeasure.
Experience in hyaluronidase use. Administering hyaluronidase belongs to the training of every medical filler practitioner. A practice without that experience does not belong in a critical patient choice. More on provider criteria in our article on provider red flags.
What hyaluronidase can and cannot do
It can: enzymatically break down hyaluronic acid filler. Relieve vascular pressure in an emergency. Render many complications reversible. Reduce asymmetric or unwanted HA volumes in a controlled way.
It cannot: dissolve calcium hydroxylapatite (Radiesse), poly-L-lactic acid (Sculptra), or other non-HA fillers. Undo damage from ischaemic tissue necrosis that has already occurred. Substitute for the awareness of a practice that would have placed the material correctly.
Risks of hyaluronidase use
Hyaluronidase is a substance of biological origin (usually obtained from sheep or bovine testes; recombinant variants are available). Allergic reactions are rare but documented. A review by Cavallini et al. (2013) in Plastic and Reconstructive Surgery describes rare anaphylactic courses requiring corresponding emergency equipment in the practice [3].
Practical consequence: a skin test is often performed before elective hyaluronidase use (small dose 20 minutes before application). With acute emergency indication, the test is omitted — the risk-benefit balance favours immediate use.
What patients should know — before and after a filler treatment
Before treatment: ask about hyaluronidase availability. "Do you have hyaluronidase in the room?" is a legitimate, sensible question. A serious practice answers yes and explains the safety concept without hesitation.
After treatment: with acute, unusual symptoms — contact the treating practice immediately. No self-diagnosis, no online research, no waiting. Speed is the decisive factor in an emergency. More on possible warning signs in our article on recognising complications.
FAQ
Does hyaluronidase availability mean complications are likely?
No. Hyaluronidase is a safety instrument, not an expectation. Comparable to a defibrillator in a practice: its presence does not mean resuscitation is likely — it means the practice would be prepared.
How quickly does hyaluronidase work?
In acute use: visible effects often within minutes to a few hours. Complete material breakdown: 24–72 hours, depending on dose and filler type.
Is all the filler material dissolved?
With correct dosing: largely. In emergency use, flooding doses are often given to maximise effect within the time window. In elective correction, individual filler portions can be dissolved selectively.
Does the hyaluronidase injection hurt?
Comparable to the original filler injection. In emergency use, effect comes first, not comfort. In elective use, local anaesthesia is often used.
Can I get hyaluronidase at any practice?
In theory, at any medical practice working with HA filler — practically, only if it stocks hyaluronidase. With a suspected emergency, primarily contact the practice that placed the filler.
Does hyaluronidase work on filler that has been in place for years?
Yes. Hyaluronic acid filler that persists in tissue years after injection can be enzymatically broken down. Higher doses and several sessions may be required.
Which practice should I choose to maximise safety?
A medical practice with filler experience, a documented emergency algorithm, hyaluronidase on hand, transparent documentation, and clear reachability after treatment. More criteria in our article on provider red flags.
Acute? Contact the treating practice immediately — no self-diagnosis. § 9 HWG (German Medicines Advertising Act) prohibits remote diagnosis. This article does not replace medical judgement.
References
- [1] DeLorenzi C. New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthetic Surgery Journal. 2017;37(7):814-825. PubMed: 28333326
- [2] Beleznay K, Carruthers JDA, Humphrey S, et al. Update on Avoiding and Treating Blindness From Fillers. Aesthetic Surgery Journal. 2019;39(6):662-674. PubMed: 30649151
- [3] Cavallini M, Gazzola R, Metalla M, Vaienti L. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthetic Surgery Journal. 2013;33(8):1167-1174. PubMed: 24197934
Last reviewed: May 2026. This article does not replace medical advice. Individual results may vary.
